Caris Life Sciences, Inc. (CAI)
NMS – Real Time Price. Currency in USD
22.48
-0.66 (-2.85%)
Market open: Aug 12, 2026, 10:41 AM EDT
22.87
-0.27 (-1.17%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
22.48
-0.66 (-2.85%)
Market open: Aug 12, 2026, 10:41 AM EDT
22.87
-0.27 (-1.17%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $690.9M significantly exceed its total debt $452.4M, ensuring strong financial flexibility
Total current assets $1.1B exceed Total current liabilities $191.4M, highlighting excellent liquidity
Debt-to-equity ratio (0.8) is near the industry average, reflecting balanced leverage
Interest coverage ratio (3x) is sufficient but not particularly strong
The company generates positive free cash flow $6.4M, supporting its financial health
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 5.53 | 6.05 | 10 | |
| Quick ratio | 4.88 | 5.63 | 10 | |
| Debt to Equity | 0.76 | 0.30 | 6.0 | |
| Debt to Assets | 0.37 | 1.04 | 6.0 | |
| Interest coverage | 2.92 | -16.91 | 7.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|
| Total Revenue | 306M | 412M | 812M | 990M |
| Gross Profit | 89M | 179M | 539M | 689M |
| Operating Income | -320M | -257M | 45M | 153M |
| Net Income | -341M | -282M | -68M | 105M |
| EBITDA | -271M | -208M | 68M | 174M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 18.57 | -54.02 | 5.0 |
| Next quarter | 0.07 | -66.21 | 1.5 |
| Current year | 26.45 | 128.13 | 10 |
| Next year | 17.86 | 212.35 | 9.5 |
| Weighted average score | 6.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 21.99 | -24.89 | 999 | -71.58 | 5.5 |
| Y/Y | 45.38 | 99.11 | 100 | 8.47 | 9.0 |
| 3y average | N/A | N/A | N/A | N/A | 1.0 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 4.1 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |